Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two New Rapid Tests Detect Ricin

By LabMedica International staff writers
Posted on 15 Apr 2009
New tests for ricin have been developed independently by two groups of scientists. More...
These tests could help safeguard people against potential acts of terrorism involving ricin and also have medical implications.

Ricin, a ribosomal inactivating protein found in castor beans, is one of the agents most likely to be used in acts of aerosol or food-related bioterrorism. It can be obtained easily, and quickly causes death when inhaled or eaten in small amounts. There is no known antidote. Quantitation of ricin also has medical applications, because ricin immunoconjugates have been used as anticancer agents. Current tests capable of identifying ricin by protein recognition methods exist but are generally slow, cumbersome, and inaccurate.

Vern Schramm and Matthew Sturm at the department of biochemistry, Albert Einstein College of Medicine of Yeshiva University (Bronx, NY, USA) developed a new test that detects the presence of active ricin in any sample by measuring the release of adenine from specific ricin substrates. Ricin-catalyzed adenine release from ribosomes stops protein synthesis and is the mechanism of action of this deadly toxin. By coupling adenine release to light formation by firefly luciferase, scientists can visualize the presence of ricin by the simple detection of light. The test can detect nanogram (one-billionth of a gram) amounts of ricin in minutes. A report of this test appeared online in the March 20, 2009 edition of Analytical Chemistry.

A highly selective three-part test was developed by John Barr and Suzanne Kalb from the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA). The test involves capturing the ricin protein using special antibodies, evaluating the enzymatic activity of the ricin protein by mass spectrometry, and identifying the ricin protein by its amino acid sequence through mass spectrometry. In laboratory tests using small amounts of ricin spiked into food and body fluids, including milk, apple juice, serum, and saliva, the scientists found that the test was highly specific and accurate in comparison to current tests. This study appeared online in the February 19, 2009 publication of Analytical Chemistry.

Related Links:

Albert Einstein College of Medicine of Yeshiva University
United States Centers for Disease Control and Prevention




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.